Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include always present findings: EEG abnormality, Global developmental delay, and Intellectual disability; and common findings: Bilateral tonic-clonic seizure, Generalized myoclonic seizure, Generalized non-motor (absence) seizure, and Recurrent hand flapping and others. 19 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 13 | Bilateral tonic-clonic seizure, Focal hemiclonic seizure, Difficulty walking (gait disturbance) |
CUX2 encodes cut like homeobox 2 (1,486 aa). Transcription factor involved in the control of neuronal proliferation and differentiation in the brain. Highest expression in Brain Cortex (16.2 TPM) and Brain Frontal Cortex BA9 (13.9 TPM).
Developmental and epileptic encephalopathy, 67 is associated with mutations in the CUX2 gene on chromosome 12.
CUX2 is classified as a druggable target (Transcription Factor category) with score 3.7.
Genetic testing for CUX2 is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 3 always present features, 5 common features.
No clinical trials have been registered for developmental and epileptic encephalopathy, 67.
20 publications have been identified in PubMed for developmental and epileptic encephalopathy, 67. Research spans Epidemiology / Natural History (50%), Review / Meta-Analysis (15%), and Case Report / Case Series (15%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 10 | 50% |
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 1:05 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Muscles | 1 | Shrinkage of the cerebellum (cerebellar atrophy) |
Arms and legs | 1 | Recurrent hand flapping |
Research summaries |
3 |
15% |
Patient case studies | 3 | 15% |
Laboratory research | 2 | 10% |
Clinical study results | 1 | 5% |
New treatment approaches | 1 | 5% |
Scheffer IE (2026). [PMID: 41627953](https://pubmed.ncbi.nlm.nih.gov/41627953/). *Epilepsia*. [Epidemiology / Natural History]
Zhang G (2026). [PMID: 41133935](https://pubmed.ncbi.nlm.nih.gov/41133935/). *Epilepsia*. [Gene Therapy / Novel Therapeutics]
Costa C (2026). [PMID: 41408964](https://pubmed.ncbi.nlm.nih.gov/41408964/). *Epilepsia*. [Basic Science / Preclinical]
Nou-Fontanet L (2026). [PMID: 41933351](https://pubmed.ncbi.nlm.nih.gov/41933351/). *Orphanet J Rare Dis*. [Review / Meta-Analysis]
Enyama D (2026). [PMID: 41837584](https://pubmed.ncbi.nlm.nih.gov/41837584/). *J Paediatr Child Health*. [Clinical Trial Publication]
Sullivan J (2026). [PMID: 41251148](https://pubmed.ncbi.nlm.nih.gov/41251148/). *Epilepsia*. [Epidemiology / Natural History]
Sapuppo A (2026). [PMID: 42193054](https://pubmed.ncbi.nlm.nih.gov/42193054/). *Curr Issues Mol Biol*. [Case Report / Case Series]
Vikin T (2026). [PMID: 41066145](https://pubmed.ncbi.nlm.nih.gov/41066145/). *Epilepsia*. [Epidemiology / Natural History]
Hanquier JN (2026). [PMID: 41509464](https://pubmed.ncbi.nlm.nih.gov/41509464/). *bioRxiv*. [Basic Science / Preclinical]
Romano F (2026). [PMID: 41344425](https://pubmed.ncbi.nlm.nih.gov/41344425/). *Eur J Med Genet*. [Case Report / Case Series]